{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/116277"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/116277","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer","abstract":"Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy.","abstract_html":"Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy.","abstract_has_math":false,"creators":["Huang, Sizhe"],"institution":"Cornell University","degree_name":"M.S., Materials Science and Engineering","degree_level":"Master of Science","degree_discipline":"Materials Science and Engineering","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Jiang, Shaoyi"],"committee_members":["Silberstein, Meredith"],"year":2024,"date_issued":"2024-08","date_published":"2024-08","updated_at":"2026-11-19T03:11:32Z","subjects":["Drug Delivery","Extracellular Vesicle","Hydrogel Implants","Zwitterioinc Materials"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/n35h-e513"],"render_values":[{"text":"https://doi.org/10.7298/n35h-e513","href":"https://doi.org/10.7298/n35h-e513","code":true}]},{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["16611847"],"render_values":[{"text":"16611847","href":null,"code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12269","ProQuest Publication ID: 31489592"],"render_values":[{"text":"ProQuest Submission ID: 12269","href":null,"code":true},{"text":"ProQuest Publication ID: 31489592","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/116277","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/116277","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F116277","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Jiang, Shaoyi"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Silberstein, Meredith"]},{"key":"dc:creator","label":"Author","values":["Huang, Sizhe"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-01-14T19:39:33Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-01-14T19:39:33Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-08"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://newcatalog.library.cornell.edu/catalog/16611847"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Materials Science and Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Master of Science"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S., Materials Science and Engineering"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Drug Delivery","Extracellular Vesicle","Hydrogel Implants","Zwitterioinc Materials"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["16611847"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/n35h-e513"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12269","ProQuest Publication ID: 31489592"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/116277"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"af38aceb-9392-4713-abf1-15816fbb93fb\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2024-08</PublicationDate> <DOI>https://doi.org/10.7298/n35h-e513</DOI> <Authors> <Author> <DisplayName>Huang, Sizhe</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>Drug Delivery</Keyword> <Keyword>Extracellular Vesicle</Keyword> <Keyword>Hydrogel Implants</Keyword> <Keyword>Zwitterioinc Materials</Keyword> <Abstract>Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Huang, Sizhe"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description","label":"Description","values":["39 pages"]},{"key":"dc:description.abstract","label":"Abstract","values":["Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dcterms:license","label":"Dcterms License","values":["https://hdl.handle.net/1813/59810.2"]},{"key":"dc:title","label":"Title","values":["Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"af38aceb-9392-4713-abf1-15816fbb93fb\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2024-08</PublicationDate> <DOI>https://doi.org/10.7298/n35h-e513</DOI> <Authors> <Author> <DisplayName>Huang, Sizhe</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>Drug Delivery</Keyword> <Keyword>Extracellular Vesicle</Keyword> <Keyword>Hydrogel Implants</Keyword> <Keyword>Zwitterioinc Materials</Keyword> <Abstract>Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Huang, Sizhe"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Jiang, Shaoyi"],"dc:contributor.committeemember":["Silberstein, Meredith"],"dc:creator":["Huang, Sizhe"],"dc:date.accessioned":["2025-01-14T19:39:33Z"],"dc:date.available":["2025-01-14T19:39:33Z"],"dc:date.issued":["2024-08"],"dc:description":["39 pages"],"dc:description.abstract":["Zwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["16611847"],"dc:identifier.doi":["https://doi.org/10.7298/n35h-e513"],"dc:identifier.other":["ProQuest Submission ID: 12269","ProQuest Publication ID: 31489592"],"dc:identifier.uri":["https://hdl.handle.net/1813/116277"],"dc:language.iso":["en"],"dc:relation.uri":["https://newcatalog.library.cornell.edu/catalog/16611847"],"dc:subject":["Drug Delivery","Extracellular Vesicle","Hydrogel Implants","Zwitterioinc Materials"],"dcterms:license":["https://hdl.handle.net/1813/59810.2"],"dc:title":["Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Materials Science and Engineering"],"thesis:degree_level":["Master of Science"],"thesis:degree_name":["M.S., Materials Science and Engineering"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:11:32Z"}